ID AMPL_YEAST Reviewed; 514 AA. AC P14904; D6VXI5; P22060; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1994, sequence version 2. DT 02-SEP-2026, entry version 218. DE RecName: Full=Vacuolar aminopeptidase 1 {ECO:0000303|PubMed:17329814}; DE EC=3.4.11.22 {ECO:0000269|PubMed:19185714, ECO:0000269|PubMed:363165, ECO:0000269|PubMed:3890752, ECO:0000269|PubMed:5147, ECO:0000269|PubMed:6352682}; DE AltName: Full=Aminopeptidase yscI {ECO:0000303|PubMed:3916861}; DE AltName: Full=Leucine aminopeptidase IV {ECO:0000303|PubMed:6352682}; DE Short=LAPIV {ECO:0000303|PubMed:6352682}; DE AltName: Full=Lysosomal aminopeptidase III {ECO:0000303|PubMed:24493041}; DE AltName: Full=Polypeptidase {ECO:0000303|Ref.6}; DE AltName: Full=Vacuolar aminopeptidase I {ECO:0000303|PubMed:363165}; DE Flags: Precursor; GN Name=APE1 {ECO:0000303|PubMed:2689224}; GN Synonyms=API {ECO:0000303|PubMed:2651436}, LAP4 GN {ECO:0000303|PubMed:6352682}, YSC1 {ECO:0000303|PubMed:2689224}; GN OrderedLocusNames=YKL103C {ECO:0000312|SGD:S000001586}; GN ORFNames=YKL455; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=II-21; RX PubMed=2689224; DOI=10.1016/0014-5793(89)81510-8; RA Cueva R., Garcia-Alvarez N., Suarez-Rendueles P.; RT "Yeast vacuolar aminopeptidase yscI. Isolation and regulation of the APE1 RT (LAP4) structural gene."; RL FEBS Lett. 259:125-129(1989). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 46-63. RX PubMed=2651436; DOI=10.1016/s0021-9258(18)83527-x; RA Chang Y.-H., Smith J.A.; RT "Molecular cloning and sequencing of genomic DNA encoding aminopeptidase I RT from Saccharomyces cerevisiae."; RL J. Biol. Chem. 264:6979-6983(1989). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=8109175; DOI=10.1002/yea.320091113; RA Cheret G., Pallier C., Valens M., Daignan-Fornier B., Fukuhara H., RA Bolotin-Fukuhara M., Sor F.; RT "The DNA sequence analysis of the HAP4-LAP4 region on chromosome XI of RT Saccharomyces cerevisiae suggests the presence of a second aspartate RT aminotransferase gene in yeast."; RL Yeast 9:1259-1265(1993). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=8196765; DOI=10.1038/369371a0; RA Dujon B., Alexandraki D., Andre B., Ansorge W., Baladron V., RA Ballesta J.P.G., Banrevi A., Bolle P.-A., Bolotin-Fukuhara M., Bossier P., RA Bou G., Boyer J., Buitrago M.J., Cheret G., Colleaux L., RA Daignan-Fornier B., del Rey F., Dion C., Domdey H., Duesterhoeft A., RA Duesterhus S., Entian K.-D., Erfle H., Esteban P.F., Feldmann H., RA Fernandes L., Fobo G.M., Fritz C., Fukuhara H., Gabel C., Gaillon L., RA Garcia-Cantalejo J.M., Garcia-Ramirez J.J., Gent M.E., Ghazvini M., RA Goffeau A., Gonzalez A., Grothues D., Guerreiro P., Hegemann J.H., RA Hewitt N., Hilger F., Hollenberg C.P., Horaitis O., Indge K.J., RA Jacquier A., James C.M., Jauniaux J.-C., Jimenez A., Keuchel H., RA Kirchrath L., Kleine K., Koetter P., Legrain P., Liebl S., Louis E.J., RA Maia e Silva A., Marck C., Monnier A.-L., Moestl D., Mueller S., RA Obermaier B., Oliver S.G., Pallier C., Pascolo S., Pfeiffer F., RA Philippsen P., Planta R.J., Pohl F.M., Pohl T.M., Poehlmann R., RA Portetelle D., Purnelle B., Puzos V., Ramezani Rad M., Rasmussen S.W., RA Remacha M.A., Revuelta J.L., Richard G.-F., Rieger M., RA Rodrigues-Pousada C., Rose M., Rupp T., Santos M.A., Schwager C., RA Sensen C., Skala J., Soares H., Sor F., Stegemann J., Tettelin H., RA Thierry A., Tzermia M., Urrestarazu L.A., van Dyck L., RA van Vliet-Reedijk J.C., Valens M., Vandenbol M., Vilela C., Vissers S., RA von Wettstein D., Voss H., Wiemann S., Xu G., Zimmermann J., Haasemann M., RA Becker I., Mewes H.-W.; RT "Complete DNA sequence of yeast chromosome XI."; RL Nature 369:371-378(1994). RN [5] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [6] RP IDENTIFICATION, AND COFACTOR. RA Johnson M.J.; RT "Isolation and properties of a pure yeast polypeptidase."; RL J. Biol. Chem. 137:575-586(1941). RN [7] RP SUBCELLULAR LOCATION. RX PubMed=24493041; DOI=10.1007/bf00397903; RA Matile P., Wiemken A., Guyer W.; RT "A lysosomal aminopeptidase isozyme in differentiating yeast cells and RT protoplasts."; RL Planta 96:43-53(1971). RN [8] RP CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, GLYCOSYLATION, RP SUBUNIT, AND ACTIVITY REGULATION. RX PubMed=5147; DOI=10.1016/0005-2744(76)90338-7; RA Metz G., Roehm K.H.; RT "Yeast aminopeptidase I. Chemical composition and catalytic properties."; RL Biochim. Biophys. Acta 429:933-949(1976). RN [9] RP FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION. RX PubMed=363165; DOI=10.1016/0005-2744(78)90253-x; RA Frey J., Roehm K.H.; RT "Subcellular localization and levels of aminopeptidases and dipeptidase in RT Saccharomyces cerevisiae."; RL Biochim. Biophys. Acta 527:31-41(1978). RN [10] RP CATALYTIC ACTIVITY, AND COFACTOR. RX PubMed=6352682; DOI=10.1128/jb.156.1.36-48.1983; RA Trumbly R.J., Bradley G.; RT "Isolation and characterization of aminopeptidase mutants of Saccharomyces RT cerevisiae."; RL J. Bacteriol. 156:36-48(1983). RN [11] RP CATALYTIC ACTIVITY, COFACTOR, AND ACTIVITY REGULATION. RX PubMed=3890752; DOI=10.1016/0003-9861(85)90829-x; RA Roehm K.H.; RT "Chloride as allosteric effector of yeast aminopeptidase I."; RL Arch. Biochem. Biophys. 239:216-225(1985). RN [12] RP COFACTOR, AND ACTIVITY REGULATION. RX PubMed=3882418; DOI=10.1111/j.1432-1033.1985.tb08698.x; RA Roehm K.H.; RT "Metal binding to yeast aminopeptidase I."; RL Eur. J. Biochem. 146:633-639(1985). RN [13] RP NOMENCLATURE. RX PubMed=3916861; DOI=10.1002/yea.320010203; RA Achstetter T., Wolf D.H.; RT "Proteinases, proteolysis and biological control in the yeast Saccharomyces RT cerevisiae."; RL Yeast 1:139-157(1985). RN [14] RP PROTEOLYTIC PROCESSING. RX PubMed=1400574; DOI=10.1083/jcb.119.2.287; RA Klionsky D.J., Cueva R., Yaver D.S.; RT "Aminopeptidase I of Saccharomyces cerevisiae is localized to the vacuole RT independent of the secretory pathway."; RL J. Cell Biol. 119:287-299(1992). RN [15] RP PROTEOLYTIC PROCESSING. RX PubMed=8521804; DOI=10.1002/j.1460-2075.1995.tb00234.x; RA Segui-Real B., Martinez M., Sandoval I.V.; RT "Yeast aminopeptidase I is post-translationally sorted from the cytosol to RT the vacuole by a mechanism mediated by its bipartite N-terminal RT extension."; RL EMBO J. 14:5476-5484(1995). RN [16] RP SUBCELLULAR LOCATION, AND PROTEOLYTIC PROCESSING. RX PubMed=8601598; DOI=10.1083/jcb.132.6.999; RA Oda M.N., Scott S.V., Hefner-Gravink A., Caffarelli A.D., Klionsky D.J.; RT "Identification of a cytoplasm to vacuole targeting determinant in RT aminopeptidase I."; RL J. Cell Biol. 132:999-1010(1996). RN [17] RP FUNCTION, AND PROTEOLYTIC PROCESSING. RX PubMed=8901576; DOI=10.1073/pnas.93.22.12304; RA Scott S.V., Hefner-Gravink A., Morano K.A., Noda T., Ohsumi Y., RA Klionsky D.J.; RT "Cytoplasm-to-vacuole targeting and autophagy employ the same machinery to RT deliver proteins to the yeast vacuole."; RL Proc. Natl. Acad. Sci. U.S.A. 93:12304-12308(1996). RN [18] RP SUBCELLULAR LOCATION, AND SUBUNIT. RX PubMed=9151668; DOI=10.1083/jcb.137.3.609; RA Kim J., Scott S.V., Oda M.N., Klionsky D.J.; RT "Transport of a large oligomeric protein by the cytoplasm to vacuole RT protein targeting pathway."; RL J. Cell Biol. 137:609-618(1997). RN [19] RP FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=9214379; DOI=10.1083/jcb.138.1.37; RA Scott S.V., Baba M., Ohsumi Y., Klionsky D.J.; RT "Aminopeptidase I is targeted to the vacuole by a nonclassical vesicular RT mechanism."; RL J. Cell Biol. 138:37-44(1997). RN [20] RP FUNCTION. RX PubMed=9412464; DOI=10.1083/jcb.139.7.1687; RA Baba M., Osumi M., Scott S.V., Klionsky D.J., Ohsumi Y.; RT "Two distinct pathways for targeting proteins from the cytoplasm to the RT vacuole/lysosome."; RL J. Cell Biol. 139:1687-1695(1997). RN [21] RP SUBUNIT. RX PubMed=11152450; DOI=10.1074/jbc.m003846200; RA Andrei-Selmer C., Knuppel A., Satyanarayana C., Heese C., Schu P.V.; RT "A new class of mutants deficient in dodecamerization of aminopeptidase 1 RT and vacuolar transport."; RL J. Biol. Chem. 276:11606-11614(2001). RN [22] RP FUNCTION, AND INTERACTION WITH ATG19. RX PubMed=11382752; DOI=10.1074/jbc.m101438200; RA Leber R., Silles E., Sandoval I.V., Mazon M.J.; RT "Yol082p, a novel CVT protein involved in the selective targeting of RT aminopeptidase I to the yeast vacuole."; RL J. Biol. Chem. 276:29210-29217(2001). RN [23] RP FUNCTION, AND INTERACTION WITH ATG19. RX PubMed=11430817; DOI=10.1016/s1097-2765(01)00263-5; RA Scott S.V., Guan J., Hutchins M.U., Kim J., Klionsky D.J.; RT "Cvt19 is a receptor for the cytoplasm-to-vacuole targeting pathway."; RL Mol. Cell 7:1131-1141(2001). RN [24] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [25] RP FUNCTION. RX PubMed=15138258; DOI=10.1074/jbc.m404399200; RA Shintani T., Klionsky D.J.; RT "Cargo proteins facilitate the formation of transport vesicles in the RT cytoplasm to vacuole targeting pathway."; RL J. Biol. Chem. 279:29889-29894(2004). RN [26] RP CRYSTALLIZATION. RX PubMed=17329814; DOI=10.1107/s1744309107005441; RA Adachi W., Suzuki N.N., Fujioka Y., Suzuki K., Ohsumi Y., Inagaki F.; RT "Crystallization of Saccharomyces cerevisiae aminopeptidase 1, the major RT cargo protein of the Cvt pathway."; RL Acta Crystallogr. F 63:200-203(2007). RN [27] RP CATALYTIC ACTIVITY. RX PubMed=19185714; DOI=10.1016/s0076-6879(08)03206-0; RA Schu P.; RT "Aminopeptidase I enzymatic activity."; RL Methods Enzymol. 451:67-78(2008). RN [28] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [29] RP FUNCTION. RX PubMed=22123825; DOI=10.1074/jbc.m111.311696; RA Morales Quinones M., Winston J.T., Stromhaug P.E.; RT "Propeptide of aminopeptidase 1 protein mediates aggregation and vesicle RT formation in cytoplasm-to-vacuole targeting pathway."; RL J. Biol. Chem. 287:10121-10133(2012). RN [30] {ECO:0007744|PDB:4R8F} RP X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 46-514. RX PubMed=26208681; DOI=10.1080/15548627.2015.1067363; RA Su M.Y., Peng W.H., Ho M.R., Su S.C., Chang Y.C., Chen G.C., Chang C.I.; RT "Structure of yeast Ape1 and its role in autophagic vesicle formation."; RL Autophagy 11:1580-1593(2015). RN [31] {ECO:0007744|PDB:5JGE, ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9, ECO:0007744|PDB:5JHC} RP X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 46-514 IN COMPLEX WITH ZN(2+). RX PubMed=27320913; DOI=10.1016/j.celrep.2016.05.066; RA Yamasaki A., Watanabe Y., Adachi W., Suzuki K., Matoba K., Kirisako H., RA Kumeta H., Nakatogawa H., Ohsumi Y., Inagaki F., Noda N.N.; RT "Structural basis for receptor-mediated selective autophagy of RT aminopeptidase I aggregates."; RL Cell Rep. 16:19-27(2016). RN [32] {ECO:0007744|PDB:5JM9} RP STRUCTURE BY ELECTRON MICROSCOPY (24.00 ANGSTROMS). RX PubMed=27266708; DOI=10.15252/embr.201541960; RA Bertipaglia C., Schneider S., Jakobi A.J., Tarafder A.K., Bykov Y.S., RA Picco A., Kukulski W., Kosinski J., Hagen W.J., Ravichandran A.C., RA Wilmanns M., Wilmanns M., Kaksonen M., Briggs J.A., Sachse C.; RT "Higher-order assemblies of oligomeric cargo receptor complexes form the RT membrane scaffold of the Cvt vesicle."; RL EMBO Rep. 17:1044-1060(2016). CC -!- FUNCTION: Resident vacuolar enzyme that catalyzes the removal of amino CC acids from the N-terminus of peptides and proteins. Also acts as the CC major cargo protein of the cytoplasm-to-vacuole targeting (Cvt) CC pathway. The precursor form of aminopeptidase 1 (prApe1) assembles into CC dodecamers and the propeptide mediates the aggregation of dodecamers CC into higher multimers. The multimers are then recognized via the CC propeptide by their receptor ATG19, and ATG19 further interacts with CC ATG11, which tethers the APE1-ATG19 complex to the pre-autophagosomal CC structure (PAS). The cargo-receptor complex (also Cvt complex) is CC selectively enwrapped by a double-membrane structure termed the Cvt CC vesicle under vegetative growth conditions and by a similar but larger CC double-membrane structure termed the autophagosome under nitrogen CC starvation conditions. The Cvt vesicle or the autophagosome fuses with CC the vacuolar membrane and release its content in the vacuolar lumen. In CC the vacuole, prApe1 is processed into mature aminopeptidase 1 (mApe1). CC {ECO:0000269|PubMed:11382752, ECO:0000269|PubMed:11430817, CC ECO:0000269|PubMed:15138258, ECO:0000269|PubMed:22123825, CC ECO:0000269|PubMed:363165, ECO:0000269|PubMed:8901576, CC ECO:0000269|PubMed:9214379, ECO:0000269|PubMed:9412464}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Release of an N-terminal amino acid, preferably a neutral or CC hydrophobic one, from a polypeptide. Aminoacyl-arylamides are poor CC substrates.; EC=3.4.11.22; Evidence={ECO:0000269|PubMed:19185714, CC ECO:0000269|PubMed:363165, ECO:0000269|PubMed:3890752, CC ECO:0000269|PubMed:5147, ECO:0000269|PubMed:6352682}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000250|UniProtKB:Q9ULA0, ECO:0000269|PubMed:3882418, CC ECO:0000269|PubMed:3890752, ECO:0000269|PubMed:5147, CC ECO:0000269|PubMed:6352682, ECO:0000269|Ref.6}; CC Note=Binds 2 Zn(2+) ions per subunit. The average amount of Zn(2+) CC bound at physiological metal concentrations will be lower than CC stoichiometric. {ECO:0000250|UniProtKB:Q9ULA0, CC ECO:0000269|PubMed:3882418, ECO:0000269|PubMed:3890752, CC ECO:0000269|PubMed:5147, ECO:0000269|PubMed:6352682, CC ECO:0000269|Ref.6}; CC -!- ACTIVITY REGULATION: Strongly and specifically activated by Cl(-) and CC Br(-), which act as positive allosteric effectors. Inactivated by CC metal-chelating agents. {ECO:0000269|PubMed:3882418, CC ECO:0000269|PubMed:3890752, ECO:0000269|PubMed:5147}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 7-8.5. {ECO:0000269|PubMed:5147}; CC -!- SUBUNIT: Homododecamer. The precursor form of aminopeptidase 1 (prApe1) CC assembles into dodecamers and further aggregates into higher multimers CC (the Ape1 complex) in the cytoplasm. The Ape1 complex is disaggregated CC in the vacuolar lumen, but mature aminopeptidase 1 (mApe1) retains its CC dodecameric form. Dodecamer assembly in the cytoplasm is essential for CC formation of an enzymatically active complex. If cytoplasmic CC homododecamerization of prApe1 is disturbed in mutants, homododecamers CC of mApe1 will form in the vacuole, but they are enzymatically inactive. CC Interacts with ATG19. {ECO:0000269|PubMed:11152450, CC ECO:0000269|PubMed:11382752, ECO:0000269|PubMed:11430817, CC ECO:0000269|PubMed:5147, ECO:0000269|PubMed:9151668}. CC -!- INTERACTION: CC P14904; P22855: AMS1; NbExp=3; IntAct=EBI-2571, EBI-10398; CC P14904; P14904: APE1; NbExp=3; IntAct=EBI-2571, EBI-2571; CC P14904; P35193: ATG19; NbExp=4; IntAct=EBI-2571, EBI-29291; CC -!- SUBCELLULAR LOCATION: Vacuole {ECO:0000269|PubMed:24493041, CC ECO:0000269|PubMed:363165, ECO:0000269|PubMed:8601598}. CC Note=Transported to the vacuole by the cytosol-to-vacuole targeting CC (Cvt) pathway. {ECO:0000269|PubMed:9151668, ECO:0000269|PubMed:9214379, CC ECO:0000269|PubMed:9412464}. CC -!- PTM: Synthesized in a precursor form (prApe1) that has an amino- CC terminal propeptide. The N-terminal extension of the 61 kDa precursor CC is proteolytically processed in two sequential steps. The first step CC involves proteinase A (PrA/PEP4) and produces a 55 kDa unstable CC intermediate (iAPI). The second step involves proteinase B (PrB/PRB1) CC and converts iAPI into the 50 kDa stable, mature enzyme (mApe1). CC {ECO:0000269|PubMed:8521804}. CC -!- MISCELLANEOUS: Present with 5730 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the peptidase M18 family. {ECO:0000305}. CC -!- CAUTION: It is unsure whether this protein is glycosylated or not. CC PubMed:5147 has shown that a preparation of aminopeptidase 1 contains CC about 12% of conjugated carbohydrate, while PubMed:1400574 could not CC identify any glycosylation, which is in agreement with the fact that CC aminopeptidase 1 does not transit through the secretory pathway. CC {ECO:0000305|PubMed:1400574, ECO:0000305|PubMed:5147}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y07522; CAA68815.1; -; Genomic_DNA. DR EMBL; M25548; AAA34738.1; -; Genomic_DNA. DR EMBL; X71133; CAA50454.1; -; Genomic_DNA. DR EMBL; Z28103; CAA81943.1; -; Genomic_DNA. DR EMBL; BK006944; DAA09055.1; -; Genomic_DNA. DR PIR; A33879; A33879. DR RefSeq; NP_012819.1; NM_001179669.1. DR PDB; 4R8F; X-ray; 2.50 A; A/B/C/D=46-514. DR PDB; 5JGE; X-ray; 1.91 A; C/F=1-20. DR PDB; 5JGF; X-ray; 1.83 A; A/B/C/D=46-514. DR PDB; 5JH9; X-ray; 2.10 A; A/B/C/D=1-514. DR PDB; 5JHC; X-ray; 3.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z/a/b/c/d=1-22. DR PDB; 5JM9; EM; 24.00 A; A=1-514. DR AlphaFoldDB; P14904; -. DR EMDB; EMD-8167; -. DR SMR; P14904; -. DR BioGRID; 34031; 93. DR DIP; DIP-1409N; -. DR FunCoup; P14904; 312. DR IntAct; P14904; 79. DR MINT; P14904; -. DR STRING; 4932.YKL103C; -. DR BindingDB; P14904; -. DR ChEMBL; CHEMBL1741175; -. DR MEROPS; M18.001; -. DR CarbonylDB; P14904; -. DR GlyCosmos; P14904; 3 sites, No reported glycans. DR GlyGen; P14904; 3 sites. DR iPTMnet; P14904; -. DR PaxDb; 4932-YKL103C; -. DR PeptideAtlas; P14904; -. DR EnsemblFungi; YKL103C_mRNA; YKL103C; YKL103C. DR GeneID; 853758; -. DR KEGG; sce:YKL103C; -. DR AGR; SGD:S000001586; -. DR SGD; S000001586; APE1. DR VEuPathDB; FungiDB:YKL103C; -. DR eggNOG; KOG2596; Eukaryota. DR HOGENOM; CLU_019532_3_0_1; -. DR InParanoid; P14904; -. DR OMA; DWPIAKI; -. DR OrthoDB; 9880441at2759; -. DR BioCyc; YEAST:YKL103C-MONOMER; -. DR BRENDA; 3.4.11.22; 984. DR BioGRID-ORCS; 853758; 0 hits in 10 CRISPR screens. DR CD-CODE; 00C0C35B; Synthetic Condensate 000282. DR CD-CODE; 35D5A3ED; Synthetic Condensate 000344. DR CD-CODE; 6697AF75; Synthetic Condensate 000332. DR CD-CODE; 67785C55; Hypersomatic shock foci. DR EvolutionaryTrace; P14904; -. DR PRO; PR:P14904; -. DR Proteomes; UP000002311; Chromosome XI. DR RNAct; P14904; protein. DR GO; GO:0034270; C:Cvt complex; IDA:SGD. DR GO; GO:0005737; C:cytoplasm; HDA:SGD. DR GO; GO:0000324; C:fungal-type vacuole; IDA:SGD. DR GO; GO:0005773; C:vacuole; EXP:UniProtKB. DR GO; GO:0004177; F:aminopeptidase activity; EXP:UniProtKB. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0070006; F:metalloaminopeptidase activity; IDA:SGD. DR GO; GO:0008270; F:zinc ion binding; IEA:InterPro. DR GO; GO:0032258; P:cytoplasm to vacuole targeting by the Cvt pathway; IMP:SGD. DR GO; GO:0006508; P:proteolysis; IEA:InterPro. DR CDD; cd05639; M18; 1. DR FunFam; 2.30.250.10:FF:000001; Aspartyl aminopeptidase 1; 1. DR Gene3D; 2.30.250.10; Aminopeptidase i, Domain 2; 1. DR Gene3D; 3.40.630.10; Zn peptidases; 1. DR InterPro; IPR001948; Peptidase_M18. DR InterPro; IPR023358; Peptidase_M18_dom2. DR PANTHER; PTHR28570; ASPARTYL AMINOPEPTIDASE; 1. DR PANTHER; PTHR28570:SF4; VACUOLAR AMINOPEPTIDASE 1; 1. DR Pfam; PF02127; Peptidase_M18; 1. DR PRINTS; PR00932; AMINO1PTASE. DR SUPFAM; SSF101821; Aminopeptidase/glucanase lid domain; 1. DR SUPFAM; SSF53187; Zn-dependent exopeptidases; 1. DR PDBsum; 4R8F; -. DR PDBsum; 5JGE; -. DR PDBsum; 5JGF; -. DR PDBsum; 5JH9; -. DR PDBsum; 5JHC; -. DR PDBsum; 5JM9; -. PE 1: Evidence at protein level; KW 3D-structure; Aminopeptidase; Direct protein sequencing; Glycoprotein; KW Hydrolase; Metal-binding; Metalloprotease; Phosphoprotein; Protease; KW Protein transport; Reference proteome; Transport; Vacuole; Zinc; Zymogen. FT PROPEP 1..45 FT /note="Required for vacuolar localization. Mediates FT aggregation and vesicle formation in Cvt pathway" FT /evidence="ECO:0000269|PubMed:2651436, FT ECO:0000269|PubMed:8521804, ECO:0000269|PubMed:8601598" FT /id="PRO_0000026806" FT CHAIN 46..514 FT /note="Vacuolar aminopeptidase 1" FT /id="PRO_0000026807" FT BINDING 132 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 210 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q9ULA0" FT BINDING 303 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 303 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 339 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q9ULA0" FT BINDING 339 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 339 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0007744|PDB:5JGF" FT BINDING 340 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0007744|PDB:5JGF" FT BINDING 340 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 385 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q9ULA0" FT BINDING 385 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT BINDING 388 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:Q9ULA0" FT BINDING 479 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0007744|PDB:5JGF, ECO:0007744|PDB:5JH9" FT SITE 45..46 FT /note="Cleavage; by protease B (PrB/PRB1)" FT /evidence="ECO:0000269|PubMed:1400574" FT MOD_RES 356 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT CARBOHYD 107 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 110 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 448 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CONFLICT 233 FT /note="T -> S (in Ref. 1; CAA68815)" FT /evidence="ECO:0000305" FT CONFLICT 323 FT /note="N -> D (in Ref. 1; CAA68815)" FT /evidence="ECO:0000305" FT CONFLICT 328 FT /note="D -> E (in Ref. 1; CAA68815)" FT /evidence="ECO:0000305" FT CONFLICT 369 FT /note="P -> A (in Ref. 1; CAA68815)" FT /evidence="ECO:0000305" FT HELIX 1..17 FT /evidence="ECO:0007829|PDB:5JGE" FT HELIX 34..43 FT /evidence="ECO:0007829|PDB:5JH9" FT STRAND 45..47 FT /evidence="ECO:0007829|PDB:5JH9" FT HELIX 48..62 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 66..79 FT /evidence="ECO:0007829|PDB:5JGF" FT TURN 92..94 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 100..106 FT /evidence="ECO:0007829|PDB:5JGF" FT TURN 107..109 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 110..116 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 122..124 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 127..132 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 136..140 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 152..154 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 157..162 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 166..168 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 173..181 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 190..195 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 205..208 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 209..211 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 213..215 FT /evidence="ECO:0007829|PDB:5JGF" FT TURN 221..224 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 228..230 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 241..243 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 246..248 FT /evidence="ECO:0007829|PDB:5JGF" FT TURN 250..254 FT /evidence="ECO:0007829|PDB:4R8F" FT HELIX 257..267 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 271..273 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 274..283 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 285..287 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 288..291 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 296..300 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 302..319 FT /evidence="ECO:0007829|PDB:5JGF" FT TURN 324..326 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 330..337 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 339..341 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 349..351 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 353..365 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 372..377 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 380..384 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 395..397 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 411..413 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 418..420 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 424..437 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 442..444 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 457..464 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 467..472 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 474..477 FT /evidence="ECO:0007829|PDB:5JGF" FT STRAND 480..486 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 489..508 FT /evidence="ECO:0007829|PDB:5JGF" FT HELIX 509..511 FT /evidence="ECO:0007829|PDB:5JH9" SQ SEQUENCE 514 AA; 57093 MW; 702A8C88A2124C24 CRC64; MEEQREILEQ LKKTLQMLTV EPSKNNQIAN EEKEKKENEN SWCILEHNYE DIAQEFIDFI YKNPTTYHVV SFFAELLDKH NFKYLSEKSN WQDSIGEDGG KFYTIRNGTN LSAFILGKNW RAEKGVGVIG SHVDALTVKL KPVSFKDTAE GYGRIAVAPY GGTLNELWLD RDLGIGGRLL YKKKGTNEIK SALVDSTPLP VCRIPSLAPH FGKPAEGPFD KEDQTIPVIG FPTPDEEGNE PPTDDEKKSP LFGKHCIHLL RYVAKLAGVE VSELIQMDLD LFDVQKGTIG GIGKHFLFAP RLDDRLCSFA AMIALICYAK DVNTEESDLF STVTLYDNEE IGSLTRQGAK GGLLESVVER SSSAFTKKPV DLHTVWANSI ILSADVNHLY NPNFPEVYLK NHFPVPNVGI TLSLDPNGHM ATDVVGTALV EELARRNGDK VQYFQIKNNS RSGGTIGPSL ASQTGARTID LGIAQLSMHS IRAATGSKDV GLGVKFFNGF FKHWRSVYDE FGEL //